# Title

 Food and Drugs. PART 7â€”ENFORCEMENT POLICY


# ID

 CFR-2018-title21-vol1.Pt. 7


# Structured Analysis Summary

| Type        | Values                                                                                                                                                                                       |
|:------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Constraints | ['before', 'exceeds', 'within', 'more than', 'less than', 'after', 'greater', 'at least']                                                                                                    |
| Duration    | ['4.0 week', '10.0 day']                                                                                                                                                                     |
| Condition   | ['until', 'unless', 'where', 'subject to', 'when', 'if']                                                                                                                                     |
| Entities    | ['United States', 'Public', 'Scope', 'Guaranty', 'Seizure', 'General', 'Telephone', 'Opportunity', 'Such', 'Food', 'Rockville, MD', 'Product', 'Information', 'Written', 'Health', 'Recall'] |


# Structured Analysis With Context

 


## Constraints

| Constraints   | Context                                                                                                                              |
|:--------------|:-------------------------------------------------------------------------------------------------------------------------------------|
| after         | of an article shall expire when such article, after shipment or delivery by the person who gave                                      |
| within        | such guaranty or undertaking, becomes adulterated or misbranded within the meaning of the act, or becomes an                         |
| greater       | be determined on a case-by-case basis, but is greater that 10 percent and less than 100 percent                                      |
| less than     | basis, but is greater that 10 percent and less than 100 percent of the total number of consignees;                                   |
| exceeds       | be maintained for a period of time that exceeds the shelf life and expected use of the                                               |
| at least      | and expected use of the product and is at least the length of time specified in other applicable                                     |
| before        | Opportunity for presentation of views  before  report of criminal violation.                                                         |
| more than     | (e) If  more than one person is named in a notice, a                                                                                 |
| at least      | notice and shall be received in that office at least 3 working days before the date set in                                           |
| before        | in that office at least 3 working days before  the date set in the notice.                                                           |
| before        | a person elects not to respond on or before the time scheduled, the Commissioner will, without further                               |
| more than     | If a representative appears for  more than one respondent, the representative shall submit independent documentation                 |
| before        | Conduct of a presentation of views  before  report of criminal violation.                                                            |
| within        | If materials are submitted  within 10 calendar days after receipt of the copy                                                        |
| after         | If materials are submitted within 10 calendar days  after receipt of the copy of the summary or                                      |
| before        | the presentation, as applicable, they will be considered before a final decision as to whether or not                                |
| after         | Any materials received  after the supplemental response period generally will be considered                                          |
| after         | the Commissioner's recommendation for criminal prosecution, the Commissioner, after being advised by the United States attorney that |
| before        | related to opportunities for presentation of views conducted before  report of criminal violation.                                   |
| before        | disclose records related to a section 305 presentation before  the consideration of criminal prosecution is closed.                  |
| after         | of part 20 of this chapter are applicable. after                                                                                     |
| within        | of views shall be deemed to be closed within the meaning of this section and &#167;&#8201;7.85 when                                  |
| before        | public interest in the disclosure of the names. before                                                                               |
| before        | related to a section 305 presentation of views before  public disclosure only under &#167;&#8201;20.32 of this chapter.              |


## Duration

| Duration   | Context                                                                                                                                                                                                                                         |
|:-----------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 4.0 week   | The frequency of such reports will be determined by the relative urgency of the recall and will be specified by the Food and Drug Administration in each recall case; generally the reporting interval will be between 2 and 4 weeks.           |
| 10.0 day   | If materials are submitted within 10 calendar days after receipt of the copy of the summary or transcription of the presentation, as applicable, they will be considered before a final decision as to whether or not to recommend prosecution. |


## Condition

| Condition   | Context                                                                                                                          |
|:------------|:---------------------------------------------------------------------------------------------------------------------------------|
| subject to  | (e) [Reserved]                                                                                                                   |
|             |               (f) Product means an article  subject to the jurisdiction of the Food and Drug Administration,                     |
| subject to  | (e) [Reserved]                                                                                                                   |
|             |               (f) Product means an article  subject to the jurisdiction of the Food and Drug Administration,                     |
| subject to  | an electronic product that emits radiation and is subject to  parts 1003 and 1004 of this chapter.                               |
| subject to  | involves a minor violation that would not be subject to legal action by the Food and Drug Administration                         |
| where       | temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is |
| when        | or other delivery of an article shall expire when such article, after shipment or delivery by the                                |
| if          | (g) A guaranty or undertaking,  if signed by two or more persons, shall state                                                    |
| when        | and affords better protection for consumers than seizure, when  many lots of product have been widely distributed.               |
| when        | multiple seizure, or other court action is indicated when a firm refuses to undertake a recall requested                         |
| where       | requested by the Food and Drug Administration, or where the agency has reason to believe that a                                  |
| where       | It is reserved for urgent situations  where other means for preventing use of the recalled                                       |
| where       | and Drug Administration will assist in this task where  necessary and appropriate.                                               |
| when        | may request a firm to initiate a recall when the following determinations have been made: (1) That                               |
| if          | or correction will be considered a recall only if the Food and Drug Administration regards the product                           |
| subject to  | the product as involving a violation that is subject to  legal action, e.g., seizure.                                            |
| where       | information, including the number of direct accounts and, where  necessary, the identity of the direct accounts.                 |
| if          | (7) A copy of the firm's recall communication  if  any has issued, or a proposed communication                                   |
| if          | (7) A copy of the firm's recall communication  if  any has issued, or a proposed communication                                   |
| when        | A firm may decide to recall a product when informed by the Food and Drug Administration that                                     |
| subject to  | also is considered a firm-initiated recall and is subject to  paragraphs (a) and (b) of this section.                            |
| when        | the appropriate Food and Drug Administration district office when the reason for the removal or correction is                    |
| where       | correction is not obvious or clearly understood but where it is apparent, e.g., because of complaints or                         |
| subject to  | convey: (1) That the product in question is subject to  a recall.                                                                |
| where       | customers who received the product about the recall. where                                                                       |
| when        | for class I and class II recalls and, when  appropriate, for class III recalls.                                                  |
| if          | Be brief and to the point; (ii) Ident if y clearly the product, size, lot number(s), code(s)                                     |
| where       | instructions set forth by the recalling firm and, where necessary, extend the recall to its consignees in                        |
| where       | notification of recalls of certain drugs and devices where the agency determines that public notification may cause              |
| unless      | the recall, and date and method of notification. unless                                                                          |
| when        | (c) Recall status reports are to be discontinued  when the recall is terminated by the Food and                                  |
| when        | (a) A recall will be terminated  when the Food and Drug Administration determines that all                                       |
| when        | (a) A recall will be terminated  when the Food and Drug Administration determines that all                                       |
| subject to  | it is reasonable to assume that the product subject to the recall has been removed and proper disposition                        |
| if          | (2) Notice and opportunity need not be provided  if the Commissioner has reason to believe that they                             |
| if          | (3) Notice and opportunity need not be provided  if the Commissioner contemplates recommending further investigation by the      |
| if          | provide notice and an opportunity to present views. if                                                                           |
| if          | opportunity to present views will include all violations. if                                                                     |
| where       | written communication; (2) Specify the time and place where those named may present their views; (3) Summarize                   |
| if          | presentation of views shall be scheduled on request. if                                                                          |
| if          | representative shall present a signed statement of authorization. if                                                             |
| if          | respondent may be provided at that time only if the authenticity of the representative's authority is first                      |
| if          | views will permit participation of other persons only if they appear with the respondent or the respondent's                     |
| if          | on the respondent's behalf, letters, documents, laboratory analyses, if  applicable, or other relevant information or arguments. |
| if          | to the notice, that document, or a ver if ied copy of it, may be presented by                                                    |
| if          | shall dictate a written summary of the presentation. if                                                                          |
| where       | furnished to the Food and Drug Administration office where  the respondent's views were presented.                               |
| if          | supplemental response period generally will be considered only if the final agency decision has not yet been                     |
| when        | Commissioner will so notify each person in writing. when                                                                         |
| when        | Commissioner will so notify that person, if and when the Commissioner concludes that notification will not prejudice             |
| if          | for criminal prosecution, the Commissioner will so not if y that person,                                                         |
| when        | Commissioner will so notify that person, if and when the Commissioner concludes that notification will not prejudice             |
| when        | the United States attorney has already done so. when                                                                             |
| unless      | Commissioner will so notify each person in writing, unless  the United States attorney has already done so.                      |
| when        | the United States attorney has already done so. when                                                                             |
| unless      | so notify those persons eliminated from further consideration, unless  the United States attorney has already done so.           |
| until       | section 305 presentation is available for public disclosure until consideration of criminal prosecution has been closed in       |
| when        | within the meaning of this section and &#167;&#8201;7.85 when a final decision has been made not to                              |
| when        | within the meaning of this section and &#167;&#8201;7.85 when a final decision has been made not to                              |
| when        | within the meaning of this section and &#167;&#8201;7.85 when a final decision has been made not to                              |
| when        | within the meaning of this section and &#167;&#8201;7.85 when a final decision has been made not to                              |
| unless      | or who was not prosecuted, shall be deleted, unless the Commissioner concludes that there is a compelling                        |


## Entities

| Entities      | Context                                                                                                                  |
|:--------------|:-------------------------------------------------------------------------------------------------------------------------|
| Food          | Food  and Drugs.                                                                                                         |
| Scope         | Scope .                                                                                                                  |
| Product       | Product does not include an electronic product that emits                                                                |
| Recall        | Recall does not include a market withdrawal or a                                                                         |
| Guaranty      | Guaranty .                                                                                                               |
| United States | agent of such manufacturer who resides in the United States .                                                            |
| Recall        | Recall is a voluntary action that takes place because                                                                    |
| Seizure       | Seizure , multiple seizure, or other court action is                                                                     |
| Health        | Health  hazard evaluation and recall classification.                                                                     |
| Food          | be conducted by an ad hoc committee of Food and Drug Administration scientists and will take into                        |
| Rockville, MD | 1061,  Rockville, MD  20852.                                                                                             |
| Food          | Food  and Drug Administration-requested recall.                                                                          |
| Food          | (a) The Commissioner of  Food and Drugs or designee may request a firm                                                   |
| Such          | Such notification will be by letter or telegram to                                                                       |
| Such          | Such removal or correction will be considered a recall                                                                   |
| Telephone     | Telephone calls or other personal contacts should ordinarily be                                                          |
| Public        | Public  notification of recall.                                                                                          |
| Rockville, MD | (HFI-1), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD  20857.                                          |
| Written       | Written notification that a recall is terminated will be                                                                 |
| General       | General  industry guidance.                                                                                              |
| Opportunity   | Opportunity for presentation of views before report of criminal                                                          |
| Food          | person against whom criminal prosecution under the Federal Food , Drug, and Cosmetic Act is contemplated by              |
| United States | criminal prosecution should not be recommended to a United States  attorney.                                             |
| United States | decide whether to recommend criminal prosecution to a United States  attorney on the basis of the information available. |
| Information   | Information may include statements of persons appearing on the                                                           |
| United States | (3) When a  United States attorney informs the agency that no persons recommended                                        |
| United States | (3) When a  United States attorney informs the agency that no persons recommended                                        |
| United States | (4) When a  United States attorney informs the agency of intent to prosecute                                             |
| United States | (4) When a  United States attorney informs the agency of intent to prosecute                                             |
| United States | (4) When a  United States attorney informs the agency of intent to prosecute                                             |
| United States | made not to recommend criminal prosecution to a United States attorney based on charges set forth in the                 |
| United States | made not to recommend criminal prosecution to a United States attorney based on charges set forth in the                 |


